KINDSTAR GLOBAL (09960) plans to acquire 100% equity of Guangzhou Kangcheng Weiye Biological Technology and AnchorDx Inc. respectively.

20/09/2024

GMT Eight

KINDSTAR GLOBAL (09960) announced that the company is in discussions to acquire 100% equity of Guangzhou Kangcheng Weiyue Biotechnology Co., Ltd. and AnchorDx Inc. As of the release of this announcement, the company has not signed any legally binding transaction documents regarding the proposed acquisitions. Based on the latest information available regarding the proposed acquisitions, it is expected that the proposed acquisitions will constitute a discloseable transaction for the company under Chapter 14 of the Listing Rules of The Stock Exchange of Hong Kong Limited.

Yang Yuanqing: Promote innovation with innovation, improve quality with intelligence, and promote the leapfrogging of intelligent manufacturing.

"Millennials' income shrinking, Goldman Sachs expects Australian economic growth to be dragged down"

Contact: contact@gmteight.com

KINDSTAR GLOBAL (09960) plans to acquire 100% equity of Guangzhou Kangcheng Weiye Biological Technology and AnchorDx Inc. respectively.

RECOMMEND

HK Stock Market Move | MANULIFE-S(00945) rose by over 3%, the third quarter's new manufacturing business value increased by 40.5% year-on-year, hitting a new high.

HK Stock Market Move | LI NING (02331) rises over 5% again, introducing Red Dragon China to establish a joint venture company to develop the brand's overseas market business.

Guosen: Maintains a rating of "Outperform" for CHINAHONGQIAO (01378) as Shandong Hongqiao's profits have increased quarter-on-quarter and year-on-year in the third quarter.